🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UBS expects minimal impact from Bath & Body Works' 1Q report, stays Neutral

Published 29/05/2024, 14:16
BBWI
-

On Wednesday, UBS has maintained its Neutral rating on shares of Bath & Body Works Inc. (NYSE:BBWI) with a consistent price target of $52.00.

The firm's stance is based on the assessment that the company's sales growth trends have not significantly changed since the last report on February 29th. The expectation is that Bath & Body Works will report first-quarter earnings per share (EPS) that align with forecasts and uphold its full-year outlook for 2024.

The market consensus appears to agree with UBS's prediction, suggesting that the upcoming quarterly report will not substantially affect the stock's price-to-earnings (P/E) ratio or EPS estimates from sell-side analysts. The anticipated neutrality of the report's impact is reflected in the options market, which indicates a potential stock price movement of plus or minus 7.8% around the earnings announcement. This is in contrast to a 6.0% average historical move.

UBS's analysis indicates that investor expectations are already aligned with their projections, suggesting a balanced risk-reward scenario for Bath & Body Works' stock as the first-quarter results approach. The firm anticipates that any price movement in response to the earnings report will likely be in line with historical patterns rather than the larger fluctuation currently priced into the options market.

The financial institution's commentary underscores a wait-and-see approach, as the upcoming earnings report is not expected to provide significant surprises or deviations from the current trajectory of the company. Bath & Body Works' stock performance and investor sentiment appear to be steady as the market awaits the official release of the first-quarter financial results.

InvestingPro Insights

As Bath & Body Works (NYSE:BBWI) approaches its first-quarter earnings report, a look at the real-time data from InvestingPro provides a deeper context for UBS's Neutral rating and price target. The company's market capitalization stands at a robust 10.86 billion USD, with a price-to-earnings (P/E) ratio of 12.63, indicating a potentially attractive valuation compared to industry peers. Notably, the company's P/E ratio has remained stable, with an adjusted figure of 12.59 for the last twelve months as of Q4 2024.

InvestingPro Tips highlight Bath & Body Works' history of maintaining dividend payments for 52 consecutive years, a testament to its financial stability and a positive signal for income-focused investors. Additionally, the company's liquid assets surpassing short-term obligations suggests a strong liquidity position, which is crucial in navigating the current economic landscape. For those seeking long-term growth, it's worth noting that the company has experienced a significant price uptick of 52.17% over the last six months, indicating strong investor confidence and market performance.

Investors looking for more detailed analysis and additional InvestingPro Tips can explore further insights at InvestingPro's dedicated page for Bath & Body Works. Use the coupon code PRONEWS24 to receive an additional 10% off a yearly or biyearly Pro and Pro+ subscription, where you can find a total of 7 additional tips to help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.